Gapsz
24 posts




$SLNO Soleno Therapeutics. A second death now shown on FAERS database, Case ID 26462947 with the following info: female. 10 years old, 117 kg, event data Dec 12, 2025, FDA received date Mar 4, 2026. Submitted to FDA by a "healthcare professional." Given the event date, we are curious if Soleno was aware of this as of the last earnings call, when the CFO abruptly announced his resignation which seemed to be effective almost immediately. "Cardiac Arrest;Respiratory Acidosis;Nervous System Disorder;Pulmonary Artery Dilatation;Pulmonary Hypertension;Hyperglycaemia;Brain Death;Viral Infection" FAERS currently shows 300 total cases, of which 64 are serious with 2 deaths, on a small base of 859 active patients on drug as of Dec 31. Many of the serious cases indicate hospitalization + symptoms which are often associated with risk of fatal outcome. We are thus curious if any other of these 64 serious cases resulted in fatalities, and whether Soleno management is aware of additional undisclosed fatalities of patients who were on VYKAT XR. Disclosure - We remain short Soleno Therapeutics. Please refer to the disclosures in our Aug 15, 2025 report which this post incorporates fully by reference and may be downloaded at scorpioncapital.com.











If you listen closely he says QC is slow but cuts himself off for better points to stay on topic Also almost slips up saying a real error corrected QC may never happen Also speaks about the high prices of qc stocks And pure plays will be out of business $ionq $qubt $qbts $rfti newbie investors listen up ☝️☝️☝️☝️☝️☝️☝️☝️☝️☝️☝️☝️☝️☝️☝️☝️☝️





$IONQ and Oxford Ionics merger approved by the UK government!! gov.uk/government/pub…




